Broad-spectrum cyclic boronate β-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability
Authors:
- 23 March 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 62, 116722
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Boronic Esters in Asymmetric SynthesisThe Journal of Organic Chemistry, 2013
- Synthesis and Biological Characterization of the Histone Deacetylase Inhibitor Largazole and C7- Modified AnaloguesJournal of Medicinal Chemistry, 2010
- Synthesis of a (β-acetamido-α-acetoxyethyl)boronic ester via azido boronic estersJournal of Organometallic Chemistry, 2008
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- Total Synthesis of Plusbacin A3: A Depsipeptide Antibiotic Active Against Vancomycin-Resistant BacteriaJournal of the American Chemical Society, 2007
- Hydrolysis of Third-generation Cephalosporins by Class C β-LactamasesJournal of Biological Chemistry, 2004
- Carbapenems: the pinnacle of the beta-lactam antibiotics or room for improvement?Journal of Antimicrobial Chemotherapy, 2000
- First Stereocontrolled Synthesis of the (3S,5R,7R,10R,11R)-C1−C13 Fragment of Nystatin A1The Journal of Organic Chemistry, 1999
- (Alkoxyalkyl)boronic Ester Intermediates for Asymmetric SynthesisOrganometallics, 1996
- Asymmetric hydrogenation of 3,5-Dioxoesters catalyzed by Ru-binap complex: A short step asymmetric synthesis of 6-substituted 5,6-dihydro-2-pyronesTetrahedron, 1993